Applied Genetic Technologies Corporation reported a net income of $1.2 million for the first quarter of its fiscal year compared with a net loss of $1.4 million in the same quarter of 2017.
General and administrative expenses decreased from $3.7 million to $3.2 million, while research and development expenses increased from $8.3 million to $10.1 million, according to a press release.
Total revenue for the quarter was $14 million, an increase from $10.3 million a year ago. The increase was mainly attributed to increased milestone revenue of $8.3 million and (Read more...)
Uncategorized